ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
25.95
0.40
(1.57%)
Closed December 26 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
25.95
Bid
25.95
Ask
26.80
Volume
10,535
25.60 Day's Range 26.50
17.02 52 Week Range 40.25
Market Cap
Previous Close
25.55
Open
25.60
Last Trade
2
@
25.95
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
15,657
Shares Outstanding
12,620,419
Dividend Yield
1.93%
PE Ratio
13.72
Earnings Per Share (EPS)
1.89
Revenue
799.96M
Net Profit
23.87M

About Guerbet SA

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Villepinte, Seine-saint-denis, Fra
Founded
1990
Guerbet SA is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker GBT. The last closing price for Guerbet was 25.55 €. Over the last year, Guerbet shares have traded in a share price range of 17.02 € to 40.25 €.

Guerbet currently has 12,620,419 shares outstanding. The market capitalization of Guerbet is 322.45 € million. Guerbet has a price to earnings ratio (PE ratio) of 13.72.

GBT Latest News

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30...

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM).

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM). Guerbet annonce le...

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31...

GUERBET : Calendrier financier de l'exercice 2025

GUERBET : Calendrier financier de l'exercice 2025 Calendrier financier de l’exercice 2025 Villepinte, le 31 octobre 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de...

GUERBET : Financial agenda for 2025

GUERBET : Financial agenda for 2025 Financial agenda for 2025 Villepinte, 31 October 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is...

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au...

GUERBET : Chiffre d’affaires au 30 septembre 2024.

GUERBET : Chiffre d’affaires au 30 septembre 2024. Chiffre d’affaires au 30 septembre 2024 Maintien de la dynamique de croissance Chiffre d’affaires à 9 mois : 620,5 M€, en hausse de 9,6% à TCC1...

GUERBET : Revenue at September 30, 2024.

Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER1                    In the third quarter, momentum remained strong (+5.4% at CER), driven by the...

GUERBET : Revenue at September 30, 2024.

GUERBET : Revenue at September 30, 2024. Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER1                    In the third quarter, momentum...

GUERBET : Mise à disposition du rapport financier semestriel 2024

GUERBET : Mise à disposition du rapport financier semestriel 2024   Mise à disposition du rapport financier semestriel 2024   Mise à disposition du Rapport Financier semestriel 2024 Villepinte, le...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.255.0607287449424.726.524.5895525.07576441DE
4-0.55-2.0754716981126.527.0524.251201725.47455688DE
12-11.05-29.86486486493739.3524.251565730.08850969DE
26-9.35-26.487252124635.340.2524.251132832.19649522DE
526.2531.725888324919.740.2517.021536030.61405324DE
156-10.95-29.67479674836.940.2515.281420324.15969182DE
260-16.75-39.227166276342.744.415.281148326.29583744DE

GBT - Frequently Asked Questions (FAQ)

What is the current Guerbet share price?
The current share price of Guerbet is 25.95 €
How many Guerbet shares are in issue?
Guerbet has 12,620,419 shares in issue
What is the market cap of Guerbet?
The market capitalisation of Guerbet is EUR 322.45M
What is the 1 year trading range for Guerbet share price?
Guerbet has traded in the range of 17.02 € to 40.25 € during the past year
What is the PE ratio of Guerbet?
The price to earnings ratio of Guerbet is 13.72
What is the cash to sales ratio of Guerbet?
The cash to sales ratio of Guerbet is 0.41
What is the reporting currency for Guerbet?
Guerbet reports financial results in EUR
What is the latest annual turnover for Guerbet?
The latest annual turnover of Guerbet is EUR 799.96M
What is the latest annual profit for Guerbet?
The latest annual profit of Guerbet is EUR 23.87M
What is the registered address of Guerbet?
The registered address for Guerbet is 15 RUE DES VANESSES, VILLEPINTE, SEINE-SAINT-DENIS, 93420
What is the Guerbet website address?
The website address for Guerbet is www.guerbet.com
Which industry sector does Guerbet operate in?
Guerbet operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EIFDSTour Eiffel DS
0.0432 €
(800.00%)
89.74k
SEQUASequana medical NV
2.76 €
(33.33%)
1.64M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
ALPAUPaulic Meunerie SA
1.43 €
(16.26%)
17.14k
GNROGeNeuro SA
0.081 €
(15.38%)
330.33k
MLSMLSmalto
0.0125 €
(-32.43%)
50
ALVIAVialife Sa
13.30 €
(-27.72%)
7
MLMADMade
9.25 €
(-15.91%)
255
ALALOAcheterLouerFR
0.23 €
(-14.81%)
3.92k
ALLPLLepermislibre SA
0.397 €
(-11.78%)
3.01k
ATOAtos SE
0.0023 €
(-4.17%)
396.59M
BCPBanco Comercial Portugues SA
0.451 €
(0.16%)
17.85M
LATLatecoere
0.0094 €
(3.30%)
9.13M
ALVERVergnet
0.0021 €
(-4.55%)
8.37M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M

Discussion

View Full Feed
1jas 1jas 3 minutes ago
and want to take over and run the company yourself.?
AFFU
TruthBeTold77 TruthBeTold77 3 minutes ago
You obviously have a personal agenda. Those are some pretty bold claims...and you keep accusing me and others of being "paid scammers". Again, bold statements. I'd be careful with those. I can easily prove I'm not on the payroll. It's called investing and taking a chance. It doesn't matter tho
INKW
EarningsCentral EarningsCentral 4 minutes ago
FDX
TenKay TenKay 4 minutes ago
It took me two seconds to determine it was a completely different company.

Less time than it took him to post about it and suggest it was the same SMX.

Sad.
SMX
netmoney1999 netmoney1999 5 minutes ago
Yes, you too can follow this garbage company that has no products and no future. Diluted to oblivion - another one of Shaun's failures.
ATVK
investisseur101 investisseur101 5 minutes ago
Why i can see this guy(Ten..)answer me while i blocked him ??
HMBL
JayFiore JayFiore 5 minutes ago
I don't disagree with you, probably just getting anxious for what's to come. I did do the free trial of Chaintrade.AI Market Intelligence and thought that it looked and way more legit than anything I've ever seen any OTCM company put out. The majority of these companies don't even have a working pr
OTCM
investisseur101 investisseur101 6 minutes ago
Why not..we could be merging with SMX(by YBRA)..we will see soon
SMX
EmpressMonk25 EmpressMonk25 7 minutes ago
He pulled his DD from StockTwits and said it must be true, I gotta share this!... LMAO
HMBL
govprs govprs 7 minutes ago
Isn't the q3 2024 report a current filing?  https://www.otcmarkets.com/otcapi/company/financial-report/417444/content


GDVM
splintered sunlight splintered sunlight 7 minutes ago
Completely

Totally

Somehow legal........
GMZP
getmoreshares getmoreshares 7 minutes ago
you need to get up to speed-- read the co tweets
BCAP
RealDutch RealDutch 8 minutes ago
Likhitha.... tell your father to STOP sending crappy emails to the ENTIRE SHAREHOLDER BASE !!!

YES. I am doing this publicly now.
ITUP
TenKay TenKay 8 minutes ago
You can take it up with the admins.

Good luck…!

lol.
HMBL
newmedman newmedman 8 minutes ago
Don't say that nobody didn't warn you.

cdn.bsky.app/img/feed_thumbnail/plain/did:plc:toiqrozqqam6egogoyfvyp4c/bafkreidzluit7cdsny5uufmxrdxqahbx4ag6nqln2ltzhu6o4ek5vdsble@jpeg
familyof5 familyof5 9 minutes ago
About the HMBL boards residential bashers. These guys/gals by their own admission in all reality have no plausible reason to be here. They claim to have no vested interest in HMBL. They claim to not be here on the behalf of anyone that does. They claim to not be bashing for better entries for themse
HMBL
TenKay TenKay 10 minutes ago
It means one is either desperate for some hype or stupid.

Take your pick.
HMBL
Not likely Not likely 10 minutes ago
IT and computer stuff???

You're too nice.

At least you tried throwing a football.

Reading is essential in life.

Apparently sometimes you actually have to do it...


Well not always.


As long as it
EEGI
EmpressMonk25 EmpressMonk25 11 minutes ago
At minimal this should disqualify anyone from ever posting another anything... LOL!
HMBL
RealDutch RealDutch 14 minutes ago
Laxmi is going to give himself a heart attack, before he is able to travel to Hong Kong, if you ask me.
And then Likhitha can deal with that.
ITUP
Magnum7419 Magnum7419 14 minutes ago
They say if you snooze you loose So be careful out there :)
AHRO
EmpressMonk25 EmpressMonk25 14 minutes ago
Well you can't bring into the conversation any SMX company... LOL!
SMX

Your Recent History

Delayed Upgrade Clock